Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)-Reference-Cited by-同舟云学术

Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

Published:2020-02-19 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Wang Xiumei¹,Fang Yao¹,Sun Wenbo¹,Xu Zhi²,Zhang Yanyan¹,Wei Xiaowei³,Ding Xuansheng⁴,Xu Yong¹

Affiliation:

1. Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, and Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210009, P.R. China

2. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing, Jiangsu 211166, P.R. China

3. Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China

4. School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 211198, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin;International Journal of Molecular Sciences;2024-08-07

2. Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers;Drug Resistance Updates;2024-03

3. Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review;Cancers;2024-01-25

4. Development and validation of reversed-phase-HPLC method for simultaneous quantification of fulvestrant and disulfiram in liposomes;Bioanalysis;2023-12

5. An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer;iScience;2023-07